Minerva Neurosciences Inc (NERV)
$4.58
$0.02
(0.35%)
As on 01-Sep-2026 10:36EDT
Market cap
$231 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
2.7
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-6.8 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
2.6
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-28.5
-
Face value
--
-
Shares outstanding
47,747,559
10 Years Aggregate
CFO
$-266.05 Mln
EBITDA
$-371.48 Mln
Net Profit
$-385.86 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Minerva Neurosciences (NERV)
| 13.8 | 15.0 | -6.8 | 93.9 | -18.2 | -20.8 | -26.4 |
|
BSE Sensex
| -9.1 | -1.5 | 2.9 | -3.6 | 5.9 | 6.0 | 10.5 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|
|
Minerva Neurosciences (NERV)
| 81.0 | -63.6 | 286.8 | -65.8 | -67.1 | 5.5 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Minerva Neurosciences (NERV)
|
4.6 | 231.1 | 0.0 | -394.4 | -- | -- | -- | 2.7 |
| 82.5 | 11,993.9 | 669.5 | -320.0 | -0.8 | -71.1 | -- | 26.9 | |
| 261.6 | 16,261.1 | 1,054.4 | 755.9 | 5.7 | -- | 19 | 9.8 | |
| 70.8 | 10,022.2 | 71.0 | -894.0 | -1,175.8 | -- | -- | 60.3 | |
| 55.4 | 13,491.7 | 2,435.9 | 860.6 | 31.0 | 43 | 17.4 | 7.4 | |
| 107.2 | 11,957.0 | 1,663.7 | 413.6 | 36.3 | 430 | 30.9 | 84.5 | |
| 360.7 | 10,402.8 | 440.5 | 241.5 | 33.4 | 18.7 | 44.1 | 7.8 | |
| 540.0 | 12,332.1 | 1,283.9 | -325.1 | -19.0 | -57.7 | -- | 24.0 | |
| 585.7 | 16,765.1 | 2,782.3 | 491.5 | 21.1 | 110.1 | 35.2 | 39.3 | |
| 353.8 | 9,625.4 | 0.0 | -339.1 | -- | -30.6 | -- | 7.6 |
Shareholding Pattern
View DetailsAbout Minerva Neurosciences (NERV)
Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone, which is... in Phase 3 confirmatory trial for the treatment of negative symptoms in patients with schizophrenia. Minerva Neurosciences, Inc. was incorporated in 2007 and is based in Burlington, Massachusetts. Read more
-
Executive Chairman & CEO
Dr. Remy Luthringer Ph.D.
-
Executive Chairman & CEO
Dr. Remy Luthringer Ph.D.
-
Headquarters
Burlington, MA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Minerva Neurosciences (NERV)
What is the current share price of Minerva Neurosciences Inc (NERV) Today?
The share price of Minerva Neurosciences Inc (NERV) is $4.58 (NASDAQ) as of 01-Sep-2026 10:36 EDT. Minerva Neurosciences Inc (NERV) has given a return of -18.23% in the last 3 years.
What is the current PB & PE ratio of Minerva Neurosciences Inc (NERV)?
Since, TTM earnings of Minerva Neurosciences Inc (NERV) is negative, P/E ratio is not available.
The P/B ratio of Minerva Neurosciences Inc (NERV) is 2.68 times as on 28-Aug-2026, a 48 discount to its peers’ median range of 5.18 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-0.15 |
-0.32 |
2024 |
11.69 |
-0.65 |
2023 |
-1.33 |
-1.41 |
2022 |
-0.26 |
-0.42 |
2021 |
-0.09 |
0.54 |
What is the 52 Week High and Low of Minerva Neurosciences Inc (NERV)?
The 52-week high and low of Minerva Neurosciences Inc (NERV) are Rs 12.46 and Rs 1.93 as of 01-Sep-2026.
What is the market cap of Minerva Neurosciences Inc (NERV)?
Minerva Neurosciences Inc (NERV) has a market capitalisation of $ 231 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Minerva Neurosciences Inc (NERV)?
Before investing in Minerva Neurosciences Inc (NERV), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.